DXB Chart, page-382

DXB was never going to Manufacture , Warehouse, Market, Sell, Distribute, and provide Admin , Nina has always expressed it would be a licensing agreement.

The issue you get Tym1ng is that the Licensing deal dwarfs DXB's Market Cap, as Big Pharma move forward you approach a cruxes where "why should we pay DXB $240m when we can buy them" and do keep in mind the current licensing deal is for 22% of the Global Market , DXB still have the ability to license out the next 78% of Global Markets "Value circa 700m" it's when Big Pharma think instead of paying the Royalty for the next 20 years, in fact DXB have signed an agreement that outlasts the IP,, which is a testament to managements ability to negotiate,,

Personally can see another licensing agreement between here and March..

I have had many conversations with NIna in the past and you can tell she burns the midnight oil with the team as I have had replies at 11 o'clock at night in the past..

Disclosure DXB is in my top 10 holdings,,,, I have a set Margin and am already in the Well into Green ,